Timolol/ Amiloride/ Hydrochlorothiazide
Indications
Registered South African indications:
- Hypertension
Cautions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Timolol
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Uncontrolled heart failure
- Sinus bradycardia
- Heart block
- Cardiogenic shock
- History of bronchospasm or bronchial asthma
- Chronic obstructive pulmonary disease
- Sick sinus syndrome
- Severe peripheral vascular disease
- Raynaud's disease
- Prinzmetal's angina
- Untreated phaeochromocytoma
- Metabolic acidosis
- Hypotension
- Coadministration with monoamine oxidase inhibitors
Cautions
- Pregnancy
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Elderly
- Heart failure
- Ischaemic heart disease
- Diabetes mellitus
- History of psoriasis
- Myasthenia gravis
- Abrupt withdrawal
- Thyroid disease
Amiloride
Contraindications
- Hypersensitivity to the active ingredient or any its excipients
- Severe renal impairment
- Hyperkalaemia
- Children below 18 years
- Coadministration with other potassium-sparing drugs and potassium supplements
Cautions
- Breastfeeding
- Mild to moderate renal impairment
- Hepatic impairment
- Elderly
- Patients at risk of acidosis
- Diabetes mellitus
- Resistant oedema
- May impair ability to drive and operate machinery
Hydrochlorothiazide
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Severe renal impairment
- Refractory hypokalaemia, hyponatremia, hypercalcaemia, hyperuricaemia
- Addison’s disease
- Pre-existing hypercalcaemia
Cautions
- Breastfeeding
- Mild to moderate renal impairment
- Hepatic impairment
- Elderly
- Renal artery stenosis
- Gout
- Hyperglycaemia
- Systemic lupus erythematosus
Adult dosage
Forms avail. in SA and covered in this monograph: tab
Hypertension
Timolol/ Amiloride/ Hydrochlorothiazide
10/2.5/25mg (mg)
- Oral (tab): 1-2 tab, dly
Paediatric dosage
Not established for use in children
Special populations
Recommendations for this combination product as per highest risk category when comparing individual active ingredients
Pregnancy
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Timolol
Central Nervous System Disorders
- Psychotic disorder
- Hallucination
- Depression
- Disorientation
- Confusional state
- Nightmare
- Insomnia
- Sleep disorder
- Paraesthesia
- Dizziness
- Headache
- Somnolence
- Vertigo
- Fatigue
Cardiovascular Disorders
- Atrioventricular block
- Bradycardia
- Cardiac failure
- Cyanosis
- Hypotension
- Raynaud's phenomenon
- Increase of an existing intermittent claudication
- Peripheral coldness
Respiratory Disorders
- Dyspnoea
- Bronchospasm
Gastrointestinal Disorders
- Retroperitoneal fibrosis
- Dyspepsia
- Nausea and vomiting
- Diarrhoea
Genitourinary Disorders
- Erectile dysfunction
Musculoskeletal Disorders
- Arthralgia
Skin and Subcutaneous Tissue Disorders
- Dermatitis
- Psoriasiform dermatitis
- Erythematous rash
Sensory Disorders
- Dry eye
- Visual impairment
Amiloride
Central Nervous System Disorders
- Decreased libido
- Somnolence
- Mental confusion
- Minor psychiatric changes
- Encephalopathy
- Paraesthesia
Cardiovascular Disorders
- Angina pectoris
- Arrhythmias
- Palpitations
- Postural hypotension
- Dizziness
Respiratory Disorders
- Dyspnoea
- Cough
Gastrointestinal Disorders
- Nausea and vomiting
- Constipation
- Diarrhoea
- Abdominal pain
Hepatobiliary Disorders
- Abnormal hepatic function
- Deepening of jaundice
Genitourinary Disorders
- Increase in blood urea nitrogen concentrations
- Impotence
Endocrine and Metabolic Disorders
- Hyperkalaemia
- Hyponatraemia
Skin and Subcutaneous Tissue Disorders
- Alopecia
- Rash
- Pruritus
Immune, Blood and Lymphatic System Disorders
- Aplastic anaemia
- Neutropenia
Sensory Disorders
- Visual changes
Hydrochlorothiazide
Central Nervous System Disorders
- Weakness
- Lethargy
- Drowsiness
- Restlessness
- Seizures
- Headache
- Paraesthesia
- Dizziness
Cardiovascular Disorders
- Postural hypotension
Gastrointestinal Disorders
- Nausea and vomiting
- Constipation
- Diarrhoea
- Intestinal ulceration
Hepatobiliary Disorders
- Cholestatic jaundice
- Pancreatitis
Genitourinary Disorders
- Oliguria
- Impotence
Endocrine and Metabolic Disorders
- Hypochloraemic alkalosis
- Hyponatremia
- Hypokalaemia
- Hyperglycaemia
- Hyperuricaemia
- Gout
- Hypomagnesaemia
- Anorexia
Musculoskeletal Disorders
- Muscle pain
- Cramps
Skin and Subcutaneous Tissue Disorders
- Hypersensitivity reactions
Immune, Blood and Lymphatic System Disorders
- Thrombocytopaenia
- Granulocytopaenia
- Leucopenia
- Aplastic anaemia
- Haemolytic anaemia
Sensory Disorders
- Dry mouth
- Thirst
- Yellow vision
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Timolol
- Beta blockers
- Antidiabetic agents
- Digoxin
- Clonidine
- Tricyclic antidepressants
- Barbiturates
- Phenothiazines
- Nifedipine
- Antihypertensive agents
- Anaesthetics
- Cimetidine
- Hydralazine
- Rifampicin
- Alcohol
- Prostaglandin-synthetase inhibiting agents
- Sympathomimmetic agents
- Ergot preparations
- Risperine
- Guanethidine
Amiloride
- Alcohol
- Aldesleukin
- Anaesthetics
- Antidiabetic agents
- Antiepileptics
- Non-steroidal anti-inflammatory drugs
- Antiarrhythmics
- Tricyclic antidepressants
- Monoamine oxidase inhibitors
- Antihypertensives
- Lithium
- Phenothiazines
- Corticosteroids
- Dopaminergics
- Combined oral contraceptives and oestrogens
- Trilostane
- Ciclosporin
- Tacrolimus
- Baclofen
- Nitrates
- Agents that increase serum potassium
- Alprostadil
Hydrochlorothiazide
- Digoxin
- Neuromuscular blocking agents
- Central nervous system depressants
- Corticosteroids
- Corticotrophin
- Beta-2 agonists
- Adrenaline
- Lithium
Monitoring
- Serum electrolytes
Specific cases may require
- Renal function
Mechanism of action
Timolol
Timolol is a competitive antagonist at beta-1 and beta-2 receptors. It blocks beta sympathomimetic activity particularly in the heart, the bronchi and blood vessels. Timolol reduces heart rate and force of myocardial contraction and, therefore, myocardial oxygen consumption.
Amiloride
Amiloride is a pyrazinoylguanidine derivative which acts as a potassium-sparing diuretic. It binds to sodium channels in the distal convoluted tubules and collecting ducts in the kidney, thereby inhibiting sodium reabsorption. The net negative potential of the tubular lumen is decreased, leading to potassium retention.
Hydrochlorothiazide
Hydrochlorothiazide acts primarily in the distal convoluted tubule where it inhibits sodium chloride transport. It competes for the chloride site and affects the electrolyte reabsorption by increasing sodium and chloride excretion. This reduces plasma volume indirectly and increases plasma renin activity, aldosterone secretion and urinary potassium loss.
Dosage forms
- Tablet
Formulation
COMBINATION PREPARATIONS
Timolol/ Amiloride/ Hydrochlorothiazide
Tablet 10mg/2,5mg/25mg
- Servatrin (Pharmacare)
References
1. https://drive.google.com/drive/folders/1O8BAlVt_N24ayT6XXrmObK0LSRmENobi (Mims_0/06/2017_Servatrin_tab) 2. https://drive.google.com/drive/folders/1O8BAlVt_N24ayT6XXrmObK0LSRmENobi (17/04/1989_Pharmacare_Servatrin)
Brands & products
1 product · cached snapshot- Servatrin
TABTablet· 1 product
from R534.34| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Servatrin | 10 mg;mg;mg | 30 | Pharmacare Limited, Woodmead | R534.34 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.